Call Us: +44 (0) 1752 753723[email protected]

Gene, stem cell therapies may have far-reaching implications for coronary artery grafts

A Creighton University researcher has received a National Institutes of Health grant to study the effects of gene and stem cell therapy in coronary artery bypass grafts, a first-of-its-kind undertaking that could transform the procedure, increase survival rates and dramatically reduce the possibility of re-occlusion of the grafted arteries...

Bone marrow cells show promise in degenerative, ischemic retinal diseases

Pilot study suggests a role for autologous intravitreal CD34+ cells. The safety and feasibility of intravitreal autologous CD34+ bone marrow cells as a potential therapy for retinal disease were evaluated in a pilot study. Preliminary findings demonstrated the treatment was feasible and researchers intend to pursue a larger, prospective...

New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees

D Robert G. Schwartz, the principal of Greenville, SC-based Piedmont Physical Medicine & Rehabilitation, P.A., has published a new article that looks at the benefits of stem cell therapy for knees, and highlights it as a viable and in many cases preferred alternative to arthroscopy or knee joint replacement....

Trial of new stem cell therapy for dystrophic epidermolysis bullosa (RDEB) gives promising results

Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition, recessive dystrophic epidermolysis bullosa (RDEB), have been published. RDEB is a painful skin disease in which very minor skin injury leads to blisters and poorly healing wounds. About 1,000 people in...

Stem-cell therapy shows promise in orthopedic treatment

Three San Antonio doctors are bringing the science of stem-cell therapy treatments to orthopedic injuries, a burgeoning field that caters to patients seeking to have joints or tendons rebuilt without undergoing surgery. The physicians at The Stem Cell Orthopedic Institute of Texas — a recently created division of the...

Japan makes strides toward stem cell therapy

OSAKA – Japanese researchers report taking their first steps toward possible stem-cell-based treatments for muscular dystrophy. A Kyoto University team and chemical company Asahi Kasei created skeletal muscle stem cells from induced pluripotent stem cells, or iPS cells. These were injected into a leg of a mouse with muscular...

Stem Cells Used to Treat Secondary Progressive Patients with MS in Clinical Trial

A phase 2 clinical study from an international group of research centers compared head-to-head autologous hematopoietic stem cell transplantation (AHSCT) and mitoxantrone in treating patients with secondary progressive or relapsing-remitting multiple sclerosis. The findings showed that MRI-detected brain lesions were reduced by 79% in patients undergoing AHSCT compared to...

teeth

Stem cells from your teeth could repair your eyes

Stem cells from the dental pulp of wisdom teeth can be coaxed to turn into cells of the eye’s cornea. Researchers say this could one day be used to repair corneal scarring due to infection or injury. This could also be new source of corneal transplant tissue made from...

eye

Europe Approves Holoclar®, the First Stem Cell-Based Medicinal Product

The European Commission has granted a conditional marketing authorization, under Regulation (EC) No 726/2004, to Holoclar®, an advanced therapy based on autologous stem cells and capable to restore the eyesight of patients with severe cornea damage. Holoclar® is manufactured by Holostem Terapie Avanzate (Holostem Advanced Therapies) – a spin-off...